François Montastruc (Francois Montastruc)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Topics

Oral Anticoagulants

Benign Prostatic Hyperplasia

Top Venues

Fundamental & clinical pharmacology

European journal of clinical pharmacology

Psychopharmacology

Psychological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology (2023)
Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology 79 (3) (2023)
Tanguy Taillefer de Laportalière, Adeline Jullien, Antoine Yrondi, Philippe Cestac, François Montastruc
Reporting of harms in clinical trials of esketamine in depression: a systematic review. Psychological medicine (2023)
Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology 79 (3) (2023)
Jean-Louis Montastruc, François Montastruc, Alessandra Bura Rivière
Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study. European journal of clinical pharmacology (2023)
François Montastruc, Claire de Canecaude
Tixagevimab/Cilgavimab Treatment and Cardiovascular Events: Immortal time bias. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology 79 (3) (2023)
Karima Madi, Clara Flumian, Pascale Olivier, Agnès Sommet, François Montastruc
Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review. BMJ medicine 2 (1) (2023)
Diane Merino, Alexandre Olivier Gérard, Thibaud Lavrut, Florence Askenazy, Susanne Thümmler, François Montastruc, Milou-Daniel Drici
Drug-related catatonia in youths: real-world insights from the WHO Safety Database. European child & adolescent psychiatry (2023)
Constance Bordet, Philippe Garcia, Francesco Salvo, Anthony Touafchia, Michel Galinier, Agnès Sommet, François Montastruc
Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Psychopharmacology (2022)
Constance Bordet, Philippe Garcia, Francesco Salvo, Anthony Touafchia, Michel Galinier, Agnès Sommet, François Montastruc
Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Psychopharmacology 240 (1) (2022)
Constance Bordet, Philippe Garcia, Francesco Salvo, Anthony Touafchia, Michel Galinier, Agnès Sommet, François Montastruc
Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Psychopharmacology 240 (1) (2022)
Constance Bordet, Philippe Garcia, Francesco Salvo, Anthony Touafchia, Michel Galinier, Agnès Sommet, François Montastruc
Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Psychopharmacology 240 (1) (2022)
Déborah Foltran, Clément Delmas, Clara Flumian, Pierre De Paoli, Francesco Salvo, Sophie Gautier, Milou-Daniel Drici, Clément Karsenty, François Montastruc
Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. European heart journal. Quality of care & clinical outcomes (2021)
Philippe Garcia, Alexis Revet, Antoine Yrondi, Vanessa Rousseau, Yannick Degboe, François Montastruc
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study. Drug safety 43 (12) (2020)
Cécile Conte, Vanessa Rousseau, Charlotte Vert, François Montastruc, Jean-Louis Montastruc, Geneviève Durrieu, Pascale Olivier
Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Fundamental & clinical pharmacology 34 (4) (2020)
Fabien Despas, Vanessa Rousseau, Margaux Lafaurie, Claire De Canecaude, Geneviève Durrieu, Haleh Bagheri, François Montastruc, Jean-Louis Montastruc
Are lipid-lowering drugs associated with a risk of cataract? A pharmacovigilance study. Fundamental & clinical pharmacology 33 (6) (2019)
Sibylle de Germay, Manuela Rueter, François Montastruc, Vanessa Rousseau, Maryse Lapeyre Mestre, Jean-Louis Montastruc
Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database. Fundamental & clinical pharmacology 33 (4) (2019)
Tatiana Pacheco, François Montastruc, Vanessa Rousseau, Leila Chebane, Maryse Lapeyre-Mestre, Christel Renoux, Jean-Louis Montastruc
Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study. Movement disorders : official journal of the Movement Disorder Society 35 (1) (2019)
François Montastruc, Justine Benevent, Vanessa Rousseau, Geneviève Durrieu, Agnès Sommet, Jean-Louis Montastruc
Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase®. Fundamental & clinical pharmacology 33 (1) (2018)
Justine Benevent, Caroline Hurault-Delarue, Mélanie Araujo, François Montastruc, Jean-Louis Montastruc, Isabelle Lacroix, Christine Damase-Michel
Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties. Fundamental & clinical pharmacology 33 (3) (2018)
François Montastruc, Anne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, Fabienne Diaz-Bazin, Marie Tournier, Bernard Bégaud, Antoine Pariente
Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users. European journal of clinical pharmacology 74 (5) (2018)
François Montastruc, Justine Benevent, Anthony Touafchia, Leila Chebane, Mélanie Araujo, Emmanuelle Guitton-Bondon, Geneviève Durrieu, Christophe Arbus, Laurent Schmitt, Bernard Begaud, Jean-Louis Montastruc
Atropinic (anticholinergic) burden in antipsychotic-treated patients. Fundamental & clinical pharmacology 32 (1) (2017)
Emilie Patras de Campaigno, Emmanuelle Bondon-Guitton, Guy Laurent, François Montastruc, Jean-Louis Montastruc, Maryse Lapeyre Mestre, Fabien Despas
Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics. British journal of clinical pharmacology 83 (7) (2017)